Publications by authors named "Sheldon Spector"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

27

Total Likes

6

Extended Reach

32

Social Features

2
S
Sublingual immunotherapy: A focused allergen immunotherapy practice parameter update.
Matthew Greenhawt, John Oppenheimer, Michael Nelson, Hal Nelson, Richard Lockey, Sheldon L Spector

Ann Allergy Asthma Immunol· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data on the oral CRTh2 antagonist QAW039 (fevipiprant) in patients with uncontrolled allergic asthma.
Veit J Erpenbeck, Todor A Popov, David Miller, Steven F Weinstein, Sheldon Spector

Data Brief· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The oral CRTh2 antagonist QAW039 (fevipiprant): A phase II study in uncontrolled allergic asthma.
Veit J Erpenbeck, Todor A Popov, David Miller, Steven F Weinstein, Sheldon Spector

Pulm Pharmacol Ther· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement of sleep in patients with chronic idiopathic/spontaneous urticaria treated with omalizumab: results of three randomized, double-blind, placebo-controlled studies.
Ana M Gimenéz-Arnau, Sheldon Spector, Evgeniya Antonova, Benjamin Trzaskoma, Karin Rosén

Clin Transl Allergy· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contact dermatitis: a practice parameter-update 2015.
Luz Fonacier, David I Bernstein, Karin Pacheco, D Linn Holness, Joann Blessing-Moore, Sheldon Spector

J Allergy Clin Immunol Pract· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practice parameter for the diagnosis and management of primary immunodeficiency.
Francisco A Bonilla, David A Khan, Zuhair K Ballas, Javier Chinen, Michael M Frank, Sheldon L Spector

J Allergy Clin Immunol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anaphylaxis--a practice parameter update 2015.
Phillip Lieberman, Richard A Nicklas, Christopher Randolph, John Oppenheimer, David Bernstein, Sheldon Spector

Ann Allergy Asthma Immunol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Omalizumab in Patients with Chronic Idiopathic/Spontaneous Urticaria who Remain Symptomatic on H1 Antihistamines: A Randomized, Placebo-Controlled Study.
Sarbjit S Saini, Carsten Bindslev-Jensen, Marcus Maurer, Jean-Jacques Grob, Emel Bülbül Baskan, Sheldon Spector

J Invest Dermatol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of omalizumab in patients with chronic idiopathic/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controlled study.
Sarbjit S Saini, Carsten Bindslev-Jensen, Marcus Maurer, Jean-Jacques Grob, Emel Bülbül Baskan, Sheldon Spector

J Invest Dermatol· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Food allergy: a practice parameter update-2014.
Hugh A Sampson, Seema Aceves, S Allan Bock, John James, Stacie Jones, Sheldon Spector

J Allergy Clin Immunol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and management of rhinosinusitis: a practice parameter update.
Anju T Peters, Sheldon Spector, Joy Hsu, Daniel L Hamilos, Fuad M Baroody

Ann Allergy Asthma Immunol· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of acute loss of asthma control in the yellow zone: a practice parameter.
Chitra Dinakar, John Oppenheimer, Jay Portnoy, Leonard B Bacharier, James Li, Sheldon Spector

Ann Allergy Asthma Immunol· August 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Environmental assessment and exposure control of dust mites: a practice parameter.
Jay Portnoy, Jeffrey D Miller, P Brock Williams, Ginger L Chew, J David Miller, Sheldon Spector

Ann Allergy Asthma Immunol· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Environmental assessment and exposure reduction of cockroaches: a practice parameter.
Jay Portnoy, Ginger L Chew, Wanda Phipatanakul, P Brock Williams, Carl Grimes, Sheldon Spector

J Allergy Clin Immunol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High eosinophil count: a potential biomarker for assessing successful omalizumab treatment effects.
William Busse, Sheldon Spector, Karin Rosén, Yan Wang, Oral Alpan

J Allergy Clin Immunol· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab in persistent asthma with elevated eosinophil levels.
Sally Wenzel, Linda Ford, David Pearlman, Sheldon Spector, Lawrence Sher

N Engl J Med· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A focused parameter update: hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor-associated angioedema.
Bruce L Zuraw, Jonathan A Bernstein, David M Lang, Timothy Craig, David Dreyfus, Sheldon L Spector

J Allergy Clin Immunol· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-dependent anti-inflammatory effect of inhaled mometasone furoate/formoterol in subjects with asthma.
Hendrik Nolte, Ian Pavord, Vibeke Backer, Sheldon Spector, Tulin Shekar

Respir Med· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Omalizumab: an update on efficacy and safety in moderate-to-severe allergic asthma.
Bradley E Chipps, Maria Figliomeni, Sheldon Spector

Allergy Asthma Proc· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atopic dermatitis: a practice parameter update 2012.
Lynda Schneider, Stephen Tilles, Peter Lio, Mark Boguniewicz, Lisa Beck, Sheldon Spector

J Allergy Clin Immunol· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Environmental assessment and exposure reduction of rodents: a practice parameter.
Wanda Phipatanakul, Elizabeth Matsui, Jay Portnoy, P Brock Williams, Charles Barnes, Sheldon Spector

Ann Allergy Asthma Immunol· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is a single blood eosinophil count a reliable marker for "eosinophilic asthma?".
Sheldon Laurence Spector, Ricardo Antonio Tan

J Asthma· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exercise-induced bronchoconstriction update: therapeutic management.
Sheldon Spector, Ricardo Tan

Allergy Asthma Proc· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse reactions to vaccines practice parameter 2012 update.
John M Kelso, Matthew J Greenhawt, James T Li, Richard A Nicklas, David I Bernstein, Sheldon L Spector

J Allergy Clin Immunol· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis